The β-lactamase inhibitor avibactam (NXL104) does not induce ampC β -lactamase in Enterobacter cloacae
Christine Miossec, Monique Claudon, Premavathy Levasseur, Michael T Black Novexel, Romainville, France Abstract: Induction of ampC β-lactamase expression can often compromise antibiotic treatment and is triggered by several β-lactams (such as cefoxitin and imipenem) and by the &...
Main Authors: | Miossec C, Claudon M, Levasseur P, Black MT |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-12-01
|
Series: | Infection and Drug Resistance |
Online Access: | http://www.dovepress.com/the-beta-lactamase-inhibitor-avibactam-nxl104-does-not-induce-ampc-bet-a15161 |
Similar Items
-
Studies on the beta-lactamases of Enterobacter cloacae /
by: Findell, Charlotte Marie
Published: (1983) -
Controversies about Extended-Spectrum and AmpC Beta-Lactamases
by: Kenneth S. Thomson
Published: (2001-04-01) -
Elevating NagZ Improves Resistance to β-Lactam Antibiotics via Promoting AmpC β-Lactamase in Enterobacter cloacae
by: Xianggui Yang, et al.
Published: (2020-11-01) -
Exposure assessment of extended-spectrum beta-lactamases/AmpC beta-lactamases-producing Escherichia coli in meat in Denmark
by: Luís P. Carmo, et al.
Published: (2014-02-01) -
Prevalence of extended-spectrum beta-lactamases, AmpC beta-lactamase, and metallo-beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii in an intensive care unit in a tertiary care hospital
by: Varun Goel, et al.
Published: (2013-01-01)